199 related articles for article (PubMed ID: 24043747)
21. Recent trends in cutaneous melanoma incidence and death rates in the United States, 1992-2006.
Jemal A; Saraiya M; Patel P; Cherala SS; Barnholtz-Sloan J; Kim J; Wiggins CL; Wingo PA
J Am Acad Dermatol; 2011 Nov; 65(5 Suppl 1):S17-25.e1-3. PubMed ID: 22018063
[TBL] [Abstract][Full Text] [Related]
22. Cutaneous melanoma in Connecticut towns, 1989-91.
Polednak AP
Conn Med; 1994 Sep; 58(9):523-6. PubMed ID: 7956198
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of Sex-Specific Incidence of Melanoma.
Olsen CM; Thompson JF; Pandeya N; Whiteman DC
JAMA Dermatol; 2020 May; 156(5):553-560. PubMed ID: 32211827
[TBL] [Abstract][Full Text] [Related]
24. The incidence and mortality of cutaneous melanoma in Southern Germany: trends by anatomic site and pathologic characteristics, 1976 to 2003.
Lasithiotakis KG; Leiter U; Gorkievicz R; Eigentler T; Breuninger H; Metzler G; Strobel W; Garbe C
Cancer; 2006 Sep; 107(6):1331-9. PubMed ID: 16909413
[TBL] [Abstract][Full Text] [Related]
25. Interstate differences in incidence and mortality from melanoma. A re-examination of the latitudinal gradient.
Jones ME; Shugg D; Dwyer T; Young B; Bonett A
Med J Aust; 1992 Sep; 157(6):373-8. PubMed ID: 1447984
[TBL] [Abstract][Full Text] [Related]
26. Risk for cutaneous melanoma in recent Connecticut birth cohorts.
Roush GC; Schymura MJ; Holford TR
Am J Public Health; 1985 Jun; 75(6):679-82. PubMed ID: 4003640
[TBL] [Abstract][Full Text] [Related]
27. Annual Report to the Nation on the Status of Cancer, Featuring Cancer in Men and Women Age 20-49 Years.
Ward EM; Sherman RL; Henley SJ; Jemal A; Siegel DA; Feuer EJ; Firth AU; Kohler BA; Scott S; Ma J; Anderson RN; Benard V; Cronin KA
J Natl Cancer Inst; 2019 Dec; 111(12):1279-1297. PubMed ID: 31145458
[TBL] [Abstract][Full Text] [Related]
28. Annual Report to the Nation on the Status of Cancer, Part 1: National Cancer Statistics.
Islami F; Ward EM; Sung H; Cronin KA; Tangka FKL; Sherman RL; Zhao J; Anderson RN; Henley SJ; Yabroff KR; Jemal A; Benard VB
J Natl Cancer Inst; 2021 Nov; 113(12):1648-1669. PubMed ID: 34240195
[TBL] [Abstract][Full Text] [Related]
29. Vital signs: melanoma incidence and mortality trends and projections - United States, 1982-2030.
Guy GP; Thomas CC; Thompson T; Watson M; Massetti GM; Richardson LC;
MMWR Morb Mortal Wkly Rep; 2015 Jun; 64(21):591-6. PubMed ID: 26042651
[TBL] [Abstract][Full Text] [Related]
30. Reporting cutaneous melanoma to cancer registries in the United States.
Hall HI; Jamison P; Fulton JP; Clutter G; Roffers S; Parrish P
J Am Acad Dermatol; 2003 Oct; 49(4):624-30. PubMed ID: 14512907
[TBL] [Abstract][Full Text] [Related]
31. Annual Report to the Nation on the Status of Cancer, part I: National cancer statistics.
Cronin KA; Lake AJ; Scott S; Sherman RL; Noone AM; Howlader N; Henley SJ; Anderson RN; Firth AU; Ma J; Kohler BA; Jemal A
Cancer; 2018 Jul; 124(13):2785-2800. PubMed ID: 29786848
[TBL] [Abstract][Full Text] [Related]
32. Update on the incidence and mortality from melanoma in the United States.
Hall HI; Miller DR; Rogers JD; Bewerse B
J Am Acad Dermatol; 1999 Jan; 40(1):35-42. PubMed ID: 9922010
[TBL] [Abstract][Full Text] [Related]
33. Risk-adjusted melanoma skin cancer incidence rates in Whites (United States).
Merrill RM
Melanoma Res; 2011 Dec; 21(6):535-40. PubMed ID: 21730876
[TBL] [Abstract][Full Text] [Related]
34. Skin cancer rates in North Rhine-Westphalia, Germany before and after the introduction of the nationwide skin cancer screening program (2000-2015).
Stang A; Jöckel KH; Heidinger O
Eur J Epidemiol; 2018 Mar; 33(3):303-312. PubMed ID: 29294207
[TBL] [Abstract][Full Text] [Related]
35. Melanoma signature in Brazil: epidemiology, incidence, mortality, and trend lessons from a continental mixed population country in the past 15 years.
de Melo AC; Wainstein AJA; Buzaid AC; Thuler LCS
Melanoma Res; 2018 Dec; 28(6):629-636. PubMed ID: 30204684
[TBL] [Abstract][Full Text] [Related]
36. [Changes in the incidence and mortality rates of malignant melanoma in the Seine-Maritime region over a 20-year period].
Le Blanc C; Corven C; Courville P; Duval-Modeste AB; Boivin C; Ziadé J; De Mauroy C; Pellerin A; Bokanowski H; Dalibard F; Gremain J; Roquet ML; Chenal P; Ducastelle T; Vaquer JM; Benichou J; Joly P
Ann Dermatol Venereol; 2013 Feb; 140(2):97-104. PubMed ID: 23395490
[TBL] [Abstract][Full Text] [Related]
37. Trends in malignant melanoma of skin in New Zealand.
Cooke KR; Skegg DC; Fraser J
Int J Cancer; 1983 Jun; 31(6):715-8. PubMed ID: 6862682
[TBL] [Abstract][Full Text] [Related]
38. Malignant melanoma in Connecticut and Denmark.
Houghton A; Flannery J; Viola MV
Int J Cancer; 1980 Jan; 25(1):95-104. PubMed ID: 7399748
[TBL] [Abstract][Full Text] [Related]
39. Trends in mortality from cutaneous malignant melanoma in Spain (1982-2016): sex-specific age-cohort-period effects.
Gutiérrez-González E; López-Abente G; Aragonés N; Pollán M; Pastor-Barriuso R; Sánchez MJ; Pérez-Gómez B
J Eur Acad Dermatol Venereol; 2019 Aug; 33(8):1522-1528. PubMed ID: 30868690
[TBL] [Abstract][Full Text] [Related]
40. Time trends of incidence, mortality, and relative survival of invasive skin melanoma in Lithuania.
Stang A; Valiukeviciene S; Aleknaviciene B; Kurtinaitis J
Eur J Cancer; 2006 Mar; 42(5):660-7. PubMed ID: 16510281
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
